Results 231 to 240 of about 1,408,984 (372)

Expanding Treatment Opportunities for Hospitalized Patients with Opioid Use Disorders [PDF]

, 2017
Daniel Winetsky, Robert M. Weinrieb, Jeanmarie Perrone   +2 more
openalex   +1 more source

Landscape of informed consent practices and challenges in point‐of‐care clinical trials

Learning Health Systems, EarlyView.
Abstract Point‐of‐care trials, an approach to trial design that assesses medical product effectiveness while fully integrating research and care, represent a promising opportunity to generate practically relevant evidence efficiently for priority disease areas.
Caleigh Propes, Trevan Locke, Rachele Hendricks‐Sturrup   +2 more
wiley   +1 more source

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome [PDF]

, 2017
Niraj R. Chavan, Kristin Ashford, Amanda T. Wiggins, Michelle R. Lofwall, Agatha Critchfield   +4 more
openalex   +1 more source

Empirical calibration of a simulation model of opioid use disorder. [PDF]

PLoS One
Madushani RWMA, Wang J, Weitz M, Linas BP, White LF, Chrysanthopoulou SA.   +5 more
europepmc   +1 more source

Aligning forces to accelerate healthcare transformation: Insights from the UPMC learning community

Learning Health Systems, EarlyView.
Abstract Introduction To accelerate transformation toward value‐based, equitable care, health systems need a viable approach for engaging and aligning multiple stakeholders to promote innovation. Building and sustaining learning communities offers one possible solution.
Diane Holder, Donna Keyser, Jane Kogan, Matthew O. Hurford, John Lovelace, James Schuster   +5 more
wiley   +1 more source

A learning health system model for addressing substance use: Denver Health Center for Addiction Medicine

Learning Health Systems, EarlyView.
Abstract Introduction Substance use disorders (SUDs) continue to place heavy burdens on patients, health systems, and communities. Rapidly evolving treatment for SUDs requires health systems that can efficiently and effectively assess data and integrate evidence to practice.
Emily Bacon, Laura J. Podewils, Brooke Bender, Joshua Blum, Christian Thurstone, Alia Al‐Tayyib, John Mills, Alexandra R. Tillman, Judith Shlay   +8 more
wiley   +1 more source

Delirium‐associated medication in people at risk: A systematic update review, meta‐analyses, and GRADE‐profiles

Acta Psychiatrica Scandinavica, Volume 147, Issue 1, Page 16-42, January 2023., 2023
Abstract Background Drug‐associated delirium is a common but potentially preventable neuropsychiatric syndrome associated with detrimental outcomes. Empirical evidence for delirium‐associated medication is uncertain due to a lack of high‐quality studies.
Michael Reisinger, Eva Z. Reininghaus, Johanna De Biasi, Frederike T. Fellendorf, Daniela Schoberer   +4 more
wiley   +1 more source

Antagonist Treatment for Opioid Use Disorder [PDF]

The American Journal of Medicine, 2017
Bernard L. Silverman, Sarah C. Akerman
openaire   +3 more sources

Disentangling informing participants from obtaining their consent

Learning Health Systems, EarlyView.
Abstract Introduction Pragmatic clinical trials conducted in the context of routine care frequently satisfy the regulatory criteria for a waiver of research consent. When they do, investigators and Institutional Review Boards might assume that there is no reason to communicate any information regarding the study to participants.
Patricia Pearl O'Rourke, Joseph Ali, Judith Carrithers, David Magnus, Benjamin S. Wilfond, Sheana Bull, Laura M. Dember, Gail D'Onofrio, Julie Goldman, P. Michael Ho, Edward R. Melnick, Karen L. Staman, James A. Tulsky, Miguel A. Vazquez, Angelo Volandes, David Wendler   +15 more
wiley   +1 more source

Toward staging differentiation for posttraumatic stress disorder treatment

Acta Psychiatrica Scandinavica, Volume 147, Issue 1, Page 65-80, January 2023., 2023
Abstract Objectives Several medical and psychiatric disorders have stage‐based treatment decision‐making methods. However, international treatment guidelines for posttraumatic stress disorder (PTSD) fail to give specific treatment recommendations based on chronicity or stage of the disorder.
Mirjam J. Nijdam, Eric Vermetten, Alexander C. McFarlane   +2 more
wiley   +1 more source